Neuronetics, Inc.
STIM- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- SEC CIK
- 0001227636
In the last 90 days, Neuronetics, Inc. insiders filed 2 open-market purchases and 0 sales; 86 institutions reported holding it in 13F filings for Q2 2026, worth $48.4M in total; no superinvestor holds it.
Key figures
- Market capClose on Nov 10, 2026
- $156.2M
- Insider buysLast 90 days, $85.1K in total
- 2
- Insider sellsOpen market, last 90 days
- 0
- 13F holdersQ2 2026, −12 vs. previous quarter
- 86
- 13F valueReported value at the end of Q2 2026
- $48.4M
- Superinvestors holdingAt the end of Q2 2026
- 0
Price chart
Financials
See financial statementsFrom SEC filings, in USD.
- Revenue, FY2025
- $149.2M
- +99.2% year over year
- Net income, FY2025
- -$39.0M
- No comparable prior period
- Free cash flow, FY2025
- -$21.2M
- No comparable prior period
- Revenue, Q3 FY2026
- $42.0M
- +12.5% year over year
Revenue flow, FY2025
Green is profit; orange is costs, expenses and taxes. Percentages are shares of revenue.
Net loss for FY2025: $39.0M (26.1% of revenue).
Short interest
See short dataFrom FINRA, settlement date Oct 30, 2026.
- Short interest
- 6.66M
- Shares sold short
- Change
- −550.7K
- −7.6% vs. previous
- Days to cover
- 9.89
- At average daily volume
Superinvestors holding STIM, Q2 2026
Go to the superinvestors tabNo superinvestor reported holding STIM at the end of Q2 2026.
Latest insider trades
See all insider tradesOpen-market purchases and sales by Neuronetics, Inc. insiders from Form 4, newest first.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Nov 2, 2026 (view filing)8:49 AM ET | Oct 30 | 3 days | Chernett Jorey10% Owner | PPurchase | +18.0K | $2.27 | +$40.9K | +0.2%10.6M after | |
| Aug 17, 2026 (view filing)10:13 AM ET | Aug 14 | 3 days | Chernett Jorey10% Owner | PPurchase | +14.0K | $3.16 | +$44.2K | +0.1%10.6M after | |
| Aug 17, 2026 (view filing)10:13 AM ET | Aug 13 | 4 days | Chernett Jorey10% Owner | SSale | −10.0K | $0.0321 | −$321 | –0 after | Derivative |
| Jul 15, 2026 (view filing)9:33 AM ET | Jul 14 | 1 day | Chernett Jorey10% Owner | PPurchase | +35.0K | $1.78 | +$62.3K | +0.3%10.6M after | |
| May 21, 2026 (view filing) | Mar 19 | 63 days | Pfanstiel StevenFormer EVP, CFO and Treasurer | SSale | −8.57K | $1.34 | −$11.5K | −1.0%836.6K after | Amended |
| May 20, 2026 (view filing) | May 19 | 1 day | Chernett Jorey10% Owner | PPurchase | +100.0K | $1.17 | +$117.0K | +1.0%10.6M after | |
| May 13, 2026 (view filing) | May 12 | 1 day | Chernett Jorey10% Owner | PPurchase | +475.0K | $1.34 | +$636.5K | +4.8%10.5M after | |
| Apr 22, 2026 (view filing) | Apr 20-21 | 2 days | Chernett Jorey10% Owner | PPurchase | +200.0K | $1.55 | +$309.0K | +2.0%9.98M after | 2 lots |
| Mar 30, 2026 (view filing) | Mar 30 | Same day | Chernett Jorey10% Owner | PPurchase | +385.4K | $1.25 | +$481.8K | +4.1%9.78M after | |
| Mar 30, 2026 (view filing) | Mar 27 | 3 days | Chernett Jorey10% Owner | PPurchase | +500.0K | $1.35 | +$675.0K | +5.6%9.39M after |
Top 10 13F holders, Q2 2026
See all 86 holdersThe largest institutional positions in Neuronetics, Inc. at the end of Q2 2026; share changes are against Q1 2026.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Madryn Asset Management, LP | 18,540,488 | $24.1M | 65.29% | +64,595+0.3% | Added |
| UBS Group AG | 2,279,099 | $2.96M | 0.00% | −591,499−20.6% | Reduced |
| Wexford Capital LP | 2,002,625 | $2.60M | 0.36% | +1,301,664+185.7% | Added |
| FourWorld Capital Management LLC | 1,744,142 | $2.27M | 2.90% | +254,820+17.1% | Added |
| Lane Generational LLC | 1,633,372 | $2.12M | 1.86% | −141,252−8.0% | Reduced |
| Vanguard Capital Management LLC | 1,507,097 | $1.96M | 0.00% | −540,878−26.4% | Reduced |
| Masters Capital Management LLC | 1,000,000 | $1.30M | 0.18% | 00.0% | Unchanged |
| AdvisorShares Investments LLC | 742,795 | $965.6K | 0.12% | +125,602+20.4% | Added |
| Ikarian Capital, LLC | 701,182 | $911.5K | 0.15% | 00.0% | Unchanged |
| BlackRock, Inc. | 596,622 | $775.6K | 0.00% | −1,721,915−74.3% | Reduced |
Holders of 5% or more of STIM
See all 5 holders and filingsHolders whose latest Schedule 13D or 13G filing reports 5% or more of Neuronetics, Inc..
| Holder | Latest form | Stake | Change | First filed | Latest filing | Filing |
|---|---|---|---|---|---|---|
| Madryn Asset Management, LP | 13D/A | 30.30%20.7M shares | −1.10 ppfrom 31.40% | Dec 17, 20243 filings | Mar 4, 2026 | SEC |
| Chernett Jorey | 13D/A | 13.92%10.6M shares | −1.30 ppfrom 15.22% | Mar 18, 20266 filings | Aug 24, 2026 | SEC |
| Chernett Jorey | 13G/A | 9.90%6.83M shares | +3.50 ppfrom 6.40% | Nov 24, 20252 filings | Feb 4, 2026 | SEC |
| Parian Ultreia LP | 13G | 7.00%4.84M shares | New | Mar 17, 20261 filing | Mar 17, 2026 | SEC |
| Point72 Asset Management, L.P. | 13G | 5.00%3.82M shares | New | Aug 14, 20261 filing | Aug 14, 2026 | SEC |